The Global Nasal Spray Market is expected to be valued US$ 3.2 billion in 2022. During the projection period of 2022-2032, the market is expected to grow at a CAGR of 6.5%, generating US$ 6 billion.

Changing lifestyles across the globe, enhanced patient compliance, expanding geriatric population, and increasing pollution levels are expected to augment the market size in the forecast period. Increased demand for self-administration will offer remunerative opportunities for the global nasal spray market to expand through the assessment period. Also, various advantages provided by nasal sprays like painless drug delivery, better patient convenience, and easy availability are other vital factors promoting the market during the forecast period.

Also, growing equipment approvals by regulatory bodies are expected to benefit the market in the forecast period. For instance, in March 2019, FDA approved Spravato nasal spray for curing adult patients